AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

iBio Inc. (IBIO)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.63

-0.22 (-5.71%)

At close: Feb 20, 2025, 3:59 PM

3.86

6.48%

After-hours: Feb 20, 2025, 05:01 PM EST

undefined% (undefined)

Bid	3.65
Market Cap	35.80M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	1.3
PE Ratio (ttm)	2.79
Forward PE	n/a
Analyst	Buy

Ask	3.96
Volume	251,442
Avg. Volume (20D)	201,335
Open	3.91
Previous Close	3.85
Day's Range	3.62 - 3.99
52-Week Range	1.05 - 4.98
Beta	undefined

About IBIO

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing ...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Aug 19, 2008

Employees 16

Stock Exchange AMEX

Ticker Symbol IBIO

Website https://www.ibioinc.com

Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for IBIO stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 37.93% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

11 months ago

+192.17%

IBio shares are trading higher after the company c... Unlock content with Pro Subscription

News

10 months ago · investorplace.com

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

The healthcare industry has historically provided significant returns to investors, with a predicted CAGR of 12.71% until 2027. Although many successful and profitable companies experience a surge in ...

11 months ago · invezz.com

iBio stock nearly tripled on Wednesday: here's why

Shares of iBio Inc (NYSEAMERICAN: IBIO) close to tripled on Wednesday after the biotechnology company announced a collaboration with AstralBio Inc.

11 months ago · proactiveinvestors.com

iBio partners with AstralBio to develop obesity treatments using AI-driven platform

iBio, an AI-driven drug developer, shares surged more than 120% after it announced it has entered into a collaboration agreement with private biotech firm AstralBio to discover, engineer and develop n...

11 months ago · investorplace.com

Why Is iBio (IBIO) Stock Up 125% Today?

iBio‘s (NYSEMKT: IBIO ) shares are trending, and IBIO stock is up 125% today after the firm used two of the market's favorite buzzwords — artificial intelligence (AI) and obesity drugs — in a press re...